Predictors  ||| S:0 E:11 ||| NNP
of  ||| S:11 E:14 ||| IN
iron  ||| S:14 E:19 ||| NN
levels  ||| S:19 E:26 ||| NNS
in  ||| S:26 E:29 ||| IN
14,737  ||| S:29 E:36 ||| CD
Danish  ||| S:36 E:43 ||| JJ
blood  ||| S:43 E:49 ||| NN
donors ||| S:49 E:55 ||| NNS
:  ||| S:55 E:57 ||| :
results  ||| S:57 E:65 ||| NNS
from  ||| S:65 E:70 ||| IN
the  ||| S:70 E:74 ||| DT
Danish  ||| S:74 E:81 ||| NNP
Blood  ||| S:81 E:87 ||| NNP
Donor  ||| S:87 E:93 ||| NNP
Study  ||| S:93 E:99 ||| NNP
Dietary  ||| S:99 E:107 ||| NNP
studies  ||| S:107 E:115 ||| NNS
show  ||| S:115 E:120 ||| VBP
a  ||| S:120 E:122 ||| DT
relationship  ||| S:122 E:135 ||| NN
between  ||| S:135 E:143 ||| IN
the  ||| S:143 E:147 ||| DT
intake  ||| S:147 E:154 ||| NN
of  ||| S:154 E:157 ||| IN
iron  ||| S:157 E:162 ||| NN
enhancers  ||| S:162 E:172 ||| NNS
and  ||| S:172 E:176 ||| CC
inhibitors  ||| S:176 E:187 ||| NNS
and  ||| S:187 E:191 ||| CC
iron  ||| S:191 E:196 ||| NN
stores  ||| S:196 E:203 ||| NNS
in  ||| S:203 E:206 ||| IN
the  ||| S:206 E:210 ||| DT
general  ||| S:210 E:218 ||| JJ
population ||| S:218 E:228 ||| NN
.  ||| S:228 E:230 ||| .
However ||| S:230 E:237 ||| RB
,  ||| S:237 E:239 ||| ,
the  ||| S:239 E:243 ||| DT
impact  ||| S:243 E:250 ||| NN
of  ||| S:250 E:253 ||| IN
dietary  ||| S:253 E:261 ||| JJ
factors  ||| S:261 E:269 ||| NNS
on  ||| S:269 E:272 ||| IN
the  ||| S:272 E:276 ||| DT
iron  ||| S:276 E:281 ||| NN
stores  ||| S:281 E:288 ||| NNS
of  ||| S:288 E:291 ||| IN
blood  ||| S:291 E:297 ||| NN
donors ||| S:297 E:303 ||| NNS
,  ||| S:303 E:305 ||| ,
whose  ||| S:305 E:311 ||| WP$
iron  ||| S:311 E:316 ||| NN
status  ||| S:316 E:323 ||| NN
is  ||| S:323 E:326 ||| VBZ
affected  ||| S:326 E:335 ||| VBN
by  ||| S:335 E:338 ||| IN
blood  ||| S:338 E:344 ||| NN
donations ||| S:344 E:353 ||| NNS
,  ||| S:353 E:355 ||| ,
is  ||| S:355 E:358 ||| VBZ
incompletely  ||| S:358 E:371 ||| VBN
understood ||| S:371 E:381 ||| VBN
.  ||| S:381 E:383 ||| .
In  ||| S:383 E:386 ||| IN
the  ||| S:386 E:390 ||| DT
Danish  ||| S:390 E:397 ||| NNP
Blood  ||| S:397 E:403 ||| NNP
Donor  ||| S:403 E:409 ||| NNP
Study ||| S:409 E:414 ||| NNP
,  ||| S:414 E:416 ||| ,
we  ||| S:416 E:419 ||| PRP
assessed  ||| S:419 E:428 ||| VBD
the  ||| S:428 E:432 ||| DT
effect  ||| S:432 E:439 ||| NN
of  ||| S:439 E:442 ||| IN
blood  ||| S:442 E:448 ||| NN
donation  ||| S:448 E:457 ||| NN
frequency ||| S:457 E:466 ||| NN
,  ||| S:466 E:468 ||| ,
physiologic  ||| S:468 E:480 ||| JJ
factors ||| S:480 E:487 ||| NNS
,  ||| S:487 E:489 ||| ,
lifestyle  ||| S:489 E:499 ||| NN
and  ||| S:499 E:503 ||| CC
supplemental  ||| S:503 E:516 ||| JJ
factors ||| S:516 E:523 ||| NNS
,  ||| S:523 E:525 ||| ,
and  ||| S:525 E:529 ||| CC
dietary  ||| S:529 E:537 ||| JJ
factors  ||| S:537 E:545 ||| NNS
on  ||| S:545 E:548 ||| IN
ferritin  ||| S:548 E:557 ||| JJ
levels ||| S:557 E:563 ||| NNS
.  ||| S:563 E:565 ||| .
We  ||| S:565 E:568 ||| PRP
used  ||| S:568 E:573 ||| VBD
multiple  ||| S:573 E:582 ||| JJ
linear  ||| S:582 E:589 ||| NN
and  ||| S:589 E:593 ||| CC
logistic  ||| S:593 E:602 ||| JJ
regression  ||| S:602 E:613 ||| JJ
analyses  ||| S:613 E:622 ||| JJ
stratified  ||| S:622 E:633 ||| NN
by  ||| S:633 E:636 ||| IN
sex  ||| S:636 E:640 ||| NN
and  ||| S:640 E:644 ||| CC
menopausal  ||| S:644 E:655 ||| JJ
status ||| S:655 E:661 ||| NN
.  ||| S:661 E:663 ||| .
Among  ||| S:663 E:669 ||| IN
high-frequency  ||| S:669 E:684 ||| JJ
donors  ||| S:684 E:691 ||| NNS
( ||| S:691 E:692 ||| -LRB-
more  ||| S:692 E:697 ||| JJR
than  ||| S:697 E:702 ||| IN
nine  ||| S:702 E:707 ||| CD
donations  ||| S:707 E:717 ||| NNS
in  ||| S:717 E:720 ||| IN
the  ||| S:720 E:724 ||| DT
past  ||| S:724 E:729 ||| JJ
3  ||| S:729 E:731 ||| CD
years ||| S:731 E:736 ||| NNS
) ||| S:736 E:737 ||| -RRB-
,  ||| S:737 E:739 ||| ,
we  ||| S:739 E:742 ||| PRP
found  ||| S:742 E:748 ||| VBD
iron  ||| S:748 E:753 ||| JJ
deficiency  ||| S:753 E:764 ||| NN
( ||| S:764 E:765 ||| -LRB-
ferritin  ||| S:765 E:774 ||| FW
below  ||| S:774 E:780 ||| FW
15  ||| S:780 E:783 ||| FW
ng ||| S:783 E:785 ||| FW
/ ||| S:785 E:786 ||| FW
mL ||| S:786 E:788 ||| FW
)  ||| S:788 E:790 ||| -RRB-
in  ||| S:790 E:793 ||| IN
9 ||| S:793 E:794 ||| CD
,  ||| S:794 E:796 ||| ,
39 ||| S:796 E:798 ||| CD
,  ||| S:798 E:800 ||| ,
and  ||| S:800 E:804 ||| CC
22 ||| S:804 E:806 ||| CD
%  ||| S:806 E:808 ||| NN
of  ||| S:808 E:811 ||| IN
men ||| S:811 E:814 ||| NNS
,  ||| S:814 E:816 ||| ,
premenopausal  ||| S:816 E:830 ||| JJ
women ||| S:830 E:835 ||| NNS
,  ||| S:835 E:837 ||| ,
and  ||| S:837 E:841 ||| CC
postmenopausal  ||| S:841 E:856 ||| JJ
women ||| S:856 E:861 ||| NNS
,  ||| S:861 E:863 ||| ,
respectively ||| S:863 E:875 ||| RB
.  ||| S:875 E:877 ||| .
The  ||| S:877 E:881 ||| DT
strongest  ||| S:881 E:891 ||| JJS
predictors  ||| S:891 E:902 ||| NN
of  ||| S:902 E:905 ||| IN
iron  ||| S:905 E:910 ||| NN
deficiency  ||| S:910 E:921 ||| NN
were  ||| S:921 E:926 ||| VBD
sex ||| S:926 E:929 ||| NN
,  ||| S:929 E:931 ||| ,
menopausal  ||| S:931 E:942 ||| JJ
status ||| S:942 E:948 ||| NN
,  ||| S:948 E:950 ||| ,
the  ||| S:950 E:954 ||| DT
number  ||| S:954 E:961 ||| NN
of  ||| S:961 E:964 ||| IN
blood  ||| S:964 E:970 ||| NN
donations  ||| S:970 E:980 ||| NNS
in  ||| S:980 E:983 ||| IN
a  ||| S:983 E:985 ||| DT
3-year  ||| S:985 E:992 ||| JJ
period ||| S:992 E:998 ||| NN
,  ||| S:998 E:1000 ||| ,
and  ||| S:1000 E:1004 ||| CC
the  ||| S:1004 E:1008 ||| DT
time  ||| S:1008 E:1013 ||| NN
since  ||| S:1013 E:1019 ||| IN
last  ||| S:1019 E:1024 ||| JJ
donation ||| S:1024 E:1032 ||| NN
.  ||| S:1032 E:1034 ||| .
Other  ||| S:1034 E:1040 ||| JJ
significant  ||| S:1040 E:1052 ||| JJ
factors  ||| S:1052 E:1060 ||| NNS
included  ||| S:1060 E:1069 ||| VBD
weight ||| S:1069 E:1075 ||| NN
,  ||| S:1075 E:1077 ||| ,
age ||| S:1077 E:1080 ||| NN
,  ||| S:1080 E:1082 ||| ,
intensity  ||| S:1082 E:1092 ||| NN
of  ||| S:1092 E:1095 ||| IN
menstruation ||| S:1095 E:1107 ||| NN
,  ||| S:1107 E:1109 ||| ,
iron  ||| S:1109 E:1114 ||| NN
tablets ||| S:1114 E:1121 ||| NNS
,  ||| S:1121 E:1123 ||| ,
vitamin  ||| S:1123 E:1131 ||| JJ
pills ||| S:1131 E:1136 ||| NNS
,  ||| S:1136 E:1138 ||| ,
and  ||| S:1138 E:1142 ||| CC
consumption  ||| S:1142 E:1154 ||| NN
of  ||| S:1154 E:1157 ||| IN
meat  ||| S:1157 E:1162 ||| NN
and  ||| S:1162 E:1166 ||| CC
wine ||| S:1166 E:1170 ||| NN
.  ||| S:1170 E:1172 ||| .
The  ||| S:1172 E:1176 ||| DT
study  ||| S:1176 E:1182 ||| NN
confirms  ||| S:1182 E:1191 ||| VBZ
iron  ||| S:1191 E:1196 ||| JJ
deficiency  ||| S:1196 E:1207 ||| NN
as  ||| S:1207 E:1210 ||| IN
an  ||| S:1210 E:1213 ||| DT
important  ||| S:1213 E:1223 ||| JJ
problem ||| S:1223 E:1230 ||| NN
,  ||| S:1230 E:1232 ||| ,
especially  ||| S:1232 E:1243 ||| RB
among  ||| S:1243 E:1249 ||| IN
menstruating  ||| S:1249 E:1262 ||| JJ
women  ||| S:1262 E:1268 ||| NNS
donating  ||| S:1268 E:1277 ||| VBG
frequently ||| S:1277 E:1287 ||| RB
.  ||| S:1287 E:1289 ||| .
The  ||| S:1289 E:1293 ||| DT
risk  ||| S:1293 E:1298 ||| NN
of  ||| S:1298 E:1301 ||| IN
iron  ||| S:1301 E:1306 ||| NN
depletion  ||| S:1306 E:1316 ||| NN
was  ||| S:1316 E:1320 ||| VBD
largely  ||| S:1320 E:1328 ||| RB
explained  ||| S:1328 E:1338 ||| VBN
by  ||| S:1338 E:1341 ||| IN
sex ||| S:1341 E:1344 ||| NN
,  ||| S:1344 E:1346 ||| ,
menopausal  ||| S:1346 E:1357 ||| JJ
status ||| S:1357 E:1363 ||| NN
,  ||| S:1363 E:1365 ||| ,
and  ||| S:1365 E:1369 ||| CC
donation  ||| S:1369 E:1378 ||| JJ
frequency ||| S:1378 E:1387 ||| NN
.  ||| S:1387 E:1389 ||| .
Other  ||| S:1389 E:1395 ||| JJ
factors ||| S:1395 E:1402 ||| NNS
,  ||| S:1402 E:1404 ||| ,
including  ||| S:1404 E:1414 ||| VBG
dietary  ||| S:1414 E:1422 ||| NNS
and  ||| S:1422 E:1426 ||| CC
supplemental  ||| S:1426 E:1439 ||| JJ
iron  ||| S:1439 E:1444 ||| NN
intake ||| S:1444 E:1450 ||| NN
,  ||| S:1450 E:1452 ||| ,
had  ||| S:1452 E:1456 ||| VBD
a  ||| S:1456 E:1458 ||| DT
much  ||| S:1458 E:1463 ||| RB
weaker  ||| S:1463 E:1470 ||| JJR
effect  ||| S:1470 E:1477 ||| NN
on  ||| S:1477 E:1480 ||| IN
the  ||| S:1480 E:1484 ||| DT
risk  ||| S:1484 E:1489 ||| NN
of  ||| S:1489 E:1492 ||| IN
iron  ||| S:1492 E:1497 ||| NN
depletion ||| S:1497 E:1506 ||| NN
.  ||| S:1506 E:1508 ||| .
